Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Dendreon offering $500 million in notes
Yahoo/AP
Friday, January 14, 2011 - 9:51am
tags:
Dendreon
9 Biotech Stocks for 2011
Seeking Alpha
Friday, January 14, 2011 - 9:50am
tags:
Cepheid, Cerus, Curis, Illumina, Questcor Pharmaceuticals, CompuGen, Spectrum Pharmaceuticals, Impax, Human Genome Sciences, Vertex Pharmaceuticals, Orexigen, Dendreon
Smith & Nephew Not in Merger Talks
TheStreet.com
Friday, January 14, 2011 - 9:48am
tags:
M&A, Smith & Nephew, Biomet, JNJ
Just One Stock: The Healthcare Giant With a Low Multiple and Solid Yield
Seeking Alpha
Friday, January 14, 2011 - 9:47am
tags:
Abbott Laboratories, AstraZeneca, Bayer, JNJ, Eli Lilly, Pfizer
Cubist's Q4 Preliminary Sales Down
Yahoo/Zacks.com
Friday, January 14, 2011 - 9:46am
tags:
earnings, Cubist Pharmaceuticals
Will Watson get generic Lipitor market to itself?
Fierce Pharma
Thursday, January 13, 2011 - 1:45pm
tags:
generics, Lipitor, statins, Watson Pharmaceuticals, Pfizer, Ranbaxy
Vivus Says Erection Drug Works in 80 Percent of Men
Bloomberg
Thursday, January 13, 2011 - 1:35pm
tags:
Vivus, erectile dysfunction, Avanafil
Endo Chief Has $500 Million for Cancer, Urology Deals
Bloomberg
Thursday, January 13, 2011 - 1:32pm
tags:
cancer, Endo, M&A, urology
ALTH's Preliminary 4Q Sales Impress
Yahoo/Zacks.com
Thursday, January 13, 2011 - 1:31pm
tags:
Allos, earnings
Allergan Sues Novartis Unit Over Patents for Sanctura Medicine
Bloomberg
Thursday, January 13, 2011 - 1:30pm
tags:
Novartis, lawsuits, Allergan, Sanctura, overactive bladder
Neoprobe Looks to Become a Major Player in Oncology
Seeking Alpha
Thursday, January 13, 2011 - 1:29pm
tags:
oncology, Neoprobe, Amarin, Corcept Therapeutics, Depomed
Tracking Short Positions of 3 Biotechs With PDUFA Dates in January
Seeking Alpha
Thursday, January 13, 2011 - 1:27pm
tags:
PDUFA, biotech, Depomed, Clinical Data, Orexigen
Is Alkermes' Stock Cheap by the Numbers?
Motley Fool
Thursday, January 13, 2011 - 1:25pm
tags:
Alkermes
Shire Adds Patients, Capacity for Replagal, Vpriv
Bloomberg
Thursday, January 13, 2011 - 1:20pm
tags:
Replagal, Vpriv, Shire
European Market May Open its Doors to This Biotech
Yahoo/SmallCapInvestor
Thursday, January 13, 2011 - 1:19pm
tags:
Europe, InterMune
Cell Therapeutics raises $25M
Bizjournals.com
Thursday, January 13, 2011 - 1:18pm
tags:
Cell Therapeutics, stock offering
Biotech Firms Fight Generics
WSJ Online
Thursday, January 13, 2011 - 1:14pm
tags:
generics, biotech, Amgen, Pfizer, Enbrel, Epogen, anemia, Biogen Idec, MS, Avonex, multiple sclerosis, arthritis
Does Novo Nordisk Measure Up?
Motley Fool
Thursday, January 13, 2011 - 1:11pm
tags:
Novo Nordisk
The best biotech stocks to own now
Marketwatch
Thursday, January 13, 2011 - 12:28pm
tags:
Cerus, Curis, CompuGen, Impax, Spectrum Pharmaceuticals
Xoma and Elan: A Tale of Two Mismanaged Biotech Companies
Seeking Alpha
Thursday, January 13, 2011 - 12:22pm
tags:
Xoma, Elan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.